Travere Therapeutics, Inc. TVTX Business Segments — Total other income, net

Similar metrics at other companies

PCVXReportable Segment — Total other income, net

$25.23M-37.0%

ENPHReportable Segment — Total other income, net

$15.78M+5.4%

TWSTReportable Segment — Other Income (Expense)

$175K+144%

ZGReportable Segments — Other income, net

$16M-27.3%

RYTMSingle reportable segment — Other Income (Expense)

-$1.7M-165%

CRCTotal Reportable Segments — Other non-operating income, net

$0—

Questions, answered.

What is Travere Therapeutics, Inc.'s business segments — total other income, net?

Travere Therapeutics, Inc. (TVTX) reported business segments — total other income, net of $193K in Q1 2026.

How has Travere Therapeutics, Inc.'s business segments — total other income, net changed year-over-year?

Travere Therapeutics, Inc.'s business segments — total other income, net decreased by 87.0% year-over-year, from $1.49M to $193K.

What is the long-term trend for Travere Therapeutics, Inc.'s business segments — total other income, net?

Over 3 years (2022 to 2025), Travere Therapeutics, Inc.'s business segments — total other income, net has grown at a 6.1% compound annual growth rate (CAGR), from -$11.34M to $13.55M.

What does business segments — total other income, net mean?

This metric captures non-operating income or expenses, such as interest income, foreign exchange gains or losses, and other miscellaneous financial items. It provides a view of the company's financial performance outside of its core pharmaceutical operations.